A federal judge’s decision to revoke the FDA’s approval of the abortion pill mifepristone has led some politicians to ask the Biden Administration not to enforce the ruling. Yet NARAL Pro-Choice America President Mini Timmaraju, who’s in close contact with the White House, tells “Conversations on Health Care” that’s not the right move. “I think calls for the FDA not to comply, while you know emotionally satisfying, are not actually helpful in a litigation strategy. And our goal is for the FDA and the DOJ to prevail in this case. The ruling…is riddled with serious disinformation.”
Timmaraju explains how the Supreme Court could hear the case by the end of this week and how this judge’s opinion could have an even bigger impact on the entire health care sector. Her interview with Mark Masselli and Margaret Flinter is online now.
Podcast: Play in new window | Download
Subscribe: Apple Podcasts | Spotify | Android | Podchaser | TuneIn | RSS | More
Originally broadcast May 8, 2025 Skin cancer is the most common cancer in the United…
A recent survey surprisingly found only 41% of physicians were “very confident” about their ability…
Originally broadcast April 22, 2025 Health and Human Services Secretary Robert F. Kennedy Jr. announced…
Originally broadcast April 17, 2025 The U.S. healthcare system could save up to 500,000 lives…
Originally broadcast April 10, 2025 Eccentric billionaire Howard Hughes founded his eponymous Medical Institute over…
Originally broadcast April 3, 2025 Roughly 85% of respondents to a survey cited by Michael…